Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Little evidence found for IVF as most effective infertility treatment

29.04.2005


In vitro fertilization can improve pregnancy rates among couples with unexplained infertility, but there is little evidence to show whether IVF results in more live births than other treatments, according to a new review of recent studies.



Although expensive and invasive, IVF is a widely used treatment, despite potential complications, including a multiple pregnancy rate of about 25 percent.

According to the analysis by Dr. Zabeena Pandian of the University of Aberdeen, Scotland, and colleagues, the rate of babies born from IVF procedures is not significantly different from the rate of live births from artificial insemination and a procedure called gamete intrafallopian transfer.


The review appears in the April issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates medical research. Systematic reviews draw evidence-based conclusions about medical practice after considering both the content and quality of existing medical trials on a topic.

“There is insufficient evidence at present to suggest that IVF is more effective than the other treatment options available for unexplained infertility,” Pandian and colleagues conclude.

However, pregnancy rates were significantly higher with IVF than with “watchful waiting” and with IVF compared to gamete intrafallopian transfer, or GIFT, the researchers found. In one study comparing IVF with no treatment, 20 of 68 women receiving IVF became pregnant, while only one of 71 women were pregnant after three months of no treatment. In two studies comparing IVF with GIFT treatment, 39 of 84 women became pregnant with IVF, compared with 24 out of 85 women with GIFT.

The researchers note, however, that the studies in the review were small and varied considerably in their quality, definitions of unexplained infertility and follow-up periods.

“Until more evidence is available, IVF may not be the preferred first line of treatment for these [infertile] couples and it might be appropriate to continue with less invasive options,” Pandian says.

IVF is a process in which egg and sperm are joined to produce an embryo in the laboratory before the embryo is implanted in a woman’s uterus. In GIFT, egg and sperm are mixed in the laboratory and inserted in a woman’s fallopian tubes before the formation of an embryo. Artificial insemination involves placing a specially prepared semen sample directly into a woman’s uterus during ovulation.

IVF has become a widely accepted treatment for unexplained infertility even though very few high quality studies comparing infertility treatments exist, according to Pandian.

“IVF is becoming popular when there is no specific explanation for infertility as it may be able to overcome a variety of problems,” she says. “However, it is expensive, complicated and can have many adverse effects, including multiple births.”

The researchers found no significant differences in multiple pregnancy rates between IVF and intrauterine insemination, but there was a higher rate of multiple births in IVF recipients compared to those who received GIFT. In one study, for instance, the rate of twins was 53 percent with IVF, compared with 17 percent with GIFT.

Pandian and colleagues found no studies comparing live birth or pregnancy rates between IVF and treatment with clomiphene citrate, or Clomid, a widely used drug that stimulates ovulation.

The review included six studies with a total of 1,305 women. All patients included in the studies were part of a couple that had tired to conceive for at least one year and who had no detectable fertility abnormalities.

Pandian says that “various national laws governing IVF treatment, as well as the fact that most IVF treatments are privately funded, make it difficult to randomize clinical trials of infertility treatment.” Under these conditions, she explains, researchers have a difficult time assigning women to receive no treatment as a comparison to those receiving IVF, and many women drop out of the “no treatment” groups.

More studies used pregnancy rates as an endpoint rather than live-birth rates, however, Pandian says, “Live-birth rates per patient is the most important outcome to the couple.

A 2004 systematic review sponsored by the American Academy of Pediatrics, the American Society for Reproductive Medicine and the Genetics and Public Policy Center at Johns Hopkins University concluded that children born from IVF were at no higher risk of developing cancer, disabilities or mental disorders than their naturally conceived counterparts.

“This study was enormously valuable because it brought together all the available data and allows it to be viewed as a whole; and what we see so far is that the kids are fine,” says Dr. Robert Rebar, executive director of the American Society for Reproductive Medicine.

Z. Pandian et al. In vitro fertilisation for unexplained subfertility (Review).The Cochrane Database of Systematic Reviews 2005, Issue 2

The Cochrane Collaboration is an international nonprofit, independent organization that produces and disseminates systematic reviews of health care interventions and promotes the search for evidence in the form of clinical trials and other studies of interventions.

Zabeena Pandian | EurekAlert!
Further information:
http://www.cochrane.org
http://www.cfah.org
http://www.hbns.org

More articles from Health and Medicine:

nachricht NTU scientists build new ultrasound device using 3-D printing technology
07.12.2016 | Nanyang Technological University

nachricht How to turn white fat brown
07.12.2016 | University of Pennsylvania School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

NTU scientists build new ultrasound device using 3-D printing technology

07.12.2016 | Health and Medicine

The balancing act: An enzyme that links endocytosis to membrane recycling

07.12.2016 | Life Sciences

How to turn white fat brown

07.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>